Baidya Dalim Kumar, Agarwal Anil, Khanna Puneet, Arora Mahesh Kumar
Department of Anaesthesia and Intensive Care, All India Institute of Medical Sciences, New Delhi, India.
J Anaesthesiol Clin Pharmacol. 2011 Jul;27(3):307-14. doi: 10.4103/0970-9185.83672.
Pregabalin is a gamma-amino-butyric acid analog shown to be effective in several models of neuropathic pain, incisional injury, and inflammatory injury. In this review, the role of pregabalin in acute postoperative pain and in chronic pain syndromes has been discussed. Multimodal perioperative analgesia with the use of gabapentinoids has become common. Based on available evidence from randomized controlled trials and meta-analysis, the perioperative administration of pregabalin reduces opioid consumption and opioid-related adverse effects in the first 24 h following surgery. Postoperative pain intensity is however not consistently reduced by pregabalin. Adverse effects like visual disturbance, sedation, dizziness, and headache are associated with higher doses. The advantage of the perioperative use of pregabalin is so far limited to laparoscopic, gynecological, and daycare surgeries which are not very painful. The role of the perioperative administration of pregabalin in preventing chronic pain following surgery, its efficacy in more painful surgeries and surgeries done under regional anesthesia, and the optimal dosage and duration of perioperative pregabalin need to be studied. The efficacy of pregabalin in chronic pain conditions like painful diabetic neuropathy, postherpetic neuralgia, central neuropathic pain, and fibromyalgia has been demonstrated.
普瑞巴林是一种γ-氨基丁酸类似物,已被证明在多种神经性疼痛、切口损伤和炎性损伤模型中有效。在本综述中,已讨论了普瑞巴林在急性术后疼痛和慢性疼痛综合征中的作用。使用加巴喷丁类药物进行多模式围手术期镇痛已变得很常见。根据随机对照试验和荟萃分析的现有证据,围手术期给予普瑞巴林可减少术后24小时内的阿片类药物消耗及与阿片类药物相关的不良反应。然而,普瑞巴林并不能持续降低术后疼痛强度。高剂量使用会出现视觉障碍、镇静、头晕和头痛等不良反应。迄今为止,围手术期使用普瑞巴林的优势仅限于不太疼痛的腹腔镜手术、妇科手术和日间手术。围手术期给予普瑞巴林在预防术后慢性疼痛中的作用、其在疼痛更严重的手术和区域麻醉下进行的手术中的疗效,以及围手术期普瑞巴林的最佳剂量和持续时间尚需研究。普瑞巴林在慢性疼痛病症如疼痛性糖尿病神经病变、带状疱疹后神经痛、中枢神经性疼痛和纤维肌痛中的疗效已得到证实。